1) Structures of text passages that indicate whether a text passage describes, for example, a salutation, an anamnesis or the administration of medication, or the course of a hospital stay.[1]<\/sup><\/a><\/p>\n\n\n\n 2) Person-identifying characteristics or all descriptions that allow conclusions to be drawn about an individual patient and must therefore be subsequently anonymised for data protection reasons (e.g. personal names, address data or dates).[2]<\/sup><\/a><\/p>\n\n\n\n 3) Descriptions of key medical categories such as diagnoses, symptoms and findings;[3]<\/sup><\/a><\/p>\n\n\n\n 4) Descriptions of medications, including dosage (e.g., 50 mg, 1\/2 tablet), frequency (e.g., three times a day), route (e.g., oral or by mouth), duration, and reason;[4]<\/sup><\/a><\/p>\n\n\n\n 5) Additional medical categories in terms of content (e.g. descriptions of anatomical locations, medical tests and procedures, treatment methods) and their relations, which relate these categories to each other;<\/p>\n\n\n\n 6) Temporal references between categories and their relationships – all references to points in time and the sequence of clinical events – with the aim of being able to automatically map the information contained in the doctor’s letter onto a timeline;<\/p>\n\n\n\n 7) Descriptions of the certainty or uncertainty and the exclusion (negation) of statements, for example whether a diagnosis is formulated on a tentative basis or excluded altogether.<\/p>\n\n\n\n The first four of these seven annotation guidelines have now been published at the end of the first phase of the MII. These can be used as a starting point for the cross-consortium project German Medical Textcorpus (GeMTeX). GeMTeX starts in June 2023 and will build a German clinical reference corpus at six university hospitals (Leipzig, TU Munich, Essen, Berlin, Dresden and Erlangen).<\/p>\n\n\n\n![\"\"](\"https:\/\/www.smith.care\/wp-content\/uploads\/2023\/05\/Screenshot-Annotationsguideline-4.png\")
<\/figure><\/div>\n\n\n\n